Tottori, Japan

Fuminori Taniguchi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Nobelpharma Co., Ltd., Tottori University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fuminori Taniguchi. Retrieved from https://idiyas.com/inventor/fuminori-taniguchi-ivtopz1u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fuminori Taniguchi: Innovator in Gynecological Therapeutics

Introduction

Fuminori Taniguchi is a notable inventor based in Tottori, Japan. He has made significant contributions to the field of gynecological therapeutics, particularly through his innovative patent addressing estrogen-dependent diseases.

Latest Patents

Taniguchi holds a patent for an "Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and gynecological disease therapeutic agent using same." This invention aims to provide a therapeutic agent for estrogen-dependent gynecological diseases such as endometriosis, uterine fibroids, and uterine adenomyosis. The solution involves using an estrogen receptor α-inhibiting β partial agonist, represented by a specific formula, as an active ingredient.

Career Highlights

Throughout his career, Taniguchi has worked with reputable organizations, including Nobelpharma Co., Ltd. and Tottori University. His work has focused on developing effective treatments for gynecological conditions, showcasing his dedication to improving women's health.

Collaborations

Taniguchi has collaborated with esteemed colleagues such as Kenichiro Nakao and Tasuku Harada. These partnerships have contributed to the advancement of research and development in his field.

Conclusion

Fuminori Taniguchi's innovative work in gynecological therapeutics highlights his commitment to addressing critical health issues. His patent represents a significant step forward in the treatment of estrogen-dependent diseases, showcasing the impact of his contributions to medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…